Mismatch Prospective Cohort Study (MPC)
Brief description of study
This study will measure the amount of a protein in the brain known as tau using an imaging procedure called Positron Emission Tomography (PET/CT). Findings from this study lead to a better understanding of factors that influence the course of Alzheimer’s and other diseases of aging.
Participation in this study will include one PET/CT scan with AV-1451, a PET imaging agent. Study takes about 4 hours and will be combined with other imaging assessments from the MPC Main study.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Medical Research
-
Age: Between 18 Years - 99 Years
-
Gender: All
Participants have already agreed and consented to participate in the MPC main Study. Participants have diagnosis of Mild Cognitive Impairment ( MCI) or possible/probable Alzheimer's disease (AD).
Updated on
09 Mar 2024.
Study ID: 850679
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
